Review highlights enzyme cascade reactions for efficient synthesis of chemicals in pharmaceuticals, suggesting broad applications for sustainable manufacturing.
Enzyme cascades enable streamlined multi-step biocatalysis in one-pot systems, offering remarkable efficiency, selectivity, and sustainability compared to traditional chemical synthesis. This review highlights recent advances across three major directions: (i) efficient synthesis of bulk and chiral chemicals, including alcohol-to-amine conversion, polymer precursor biosynthesis, and non-canonical amino acid production; (ii) generation of complex pharmaceutical building blocks, exemplified by the synthesis of nucleotides, alkaloids, isoprenoids and their analogues; and (iii) integration of new-to-nature enzymatic reactions into metabolic pathways exemplified for engineered carbene-transferring P450s, artificial metalloenzymes, and photocatalytic active enzymes within microbial cell factories. These advances, driven by reaction route design, key enzyme engineering, and pathway/cell optimization, position enzyme cascades as transformative and versatile platforms for sustainable biomanufacturing across pharmaceuticals, chemicals, and materials.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: